Vice President Joe Biden's Cancer MoonShot 2020 has launched a Pediatrics Consortium led by Phoenix Children's Hospital to make combined immunotherapy the standard for pediatric cancer care.
The consortium will be launched by 10 hospitals and its aim centers on three main drivers. First, it aims to lead and use precision clinical genomic-proteomics to get the best molecular diagnosis available today. Second, it aims to reduce fragmentation across the industry between pharmaceutical companies, oncology and others to make more progress in cancer treatments. Third, it aims to establish a National Pediatrics Cancer Learning System, which is a national cloud-based system with data from academic institutions and pharmaceutical companies to accelerate clinical trial and drug development.
The following 10 hospitals will be founding members of the consortium.
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Children's Healthcare of Atlanta and its Aflac Cancer & Blood Disorders Center
- Children's Hospital of Orange County (Orange, Calif.)
- Children's Hospital of Philadelphia
- Children's Hospital of Pittsburgh of UPMC
- Duke Department of Pediatrics – Duke University School of Medicine (Durham, N.C.)
- Floating Hospital for Children at Tufts Medical Center (Boston)
- Huntsman Cancer Institute at the University of Utah and Intermountain Primary Children's Hospital (Salt Lake City)
- Phoenix Children's Hospital
- Sanford Health (Sioux Falls, S.D.)
Joining the 10 hospitals in the effort is renowned surgeon Patrick Soon-Shiong, MD, who will help Phoenix Children's launch The Chan Soon-Shiong Children's Precision Medicine Institute.
More articles on leadership and management:
Study: Physician sexual misconduct oft missed by state board
On his first day as 'full-time volunteer,' Quint Studer to host free workshop on leading and managing change
Economists doubt math on Sanders' healthcare plan